Our data on the frequency of PD-L1 positive GEP-NEN G3 is consistent with that reported by Roberts et al. in 37 GEP NEC (32%) (41) and by Kim et al. in 17 pancreatic NEN G3 patients (41%) (38). The gene discussed is CD274; the disease is neuroendocrine carcinoma.